APIXABAN
DrugBank ID: db06605
DrugCentral: apixaban
Synonymous :apixabán | apixaban | apixabanum
Drug Sentece Context
Table 1. Analysis of context sentence of apixaban gene in 13 abstracts.
pmid | sentence |
---|---|
32329231 | Plasma samples for DOAC measurement were collected 2to 4 days after starting antiviral treatment, at 12 hours from the last dose intake in patients on dabigatran and apixaban, and at 24 hours in those on rivaroxaban and edoxaban. |
32535080 | After proposing and analyzing the interaction modes of these compounds, we submitted one molecule then selected as template to a 2D similarity study in a database containing drugs approved by FDA and we have found and indicated Apixaban as a potential drug for future treatment of COVID-19. |
32685886 | Strikingly, envelope TF is essential for HSV1 infection in mice, and the FXa-directed oral anticoagulant apixaban had remarkable antiviral efficacy. |
32687485 | She was switched to Apixaban on discharge. |
32689586 | We report a case of ophthalmic artery occlusion (OAO) in a young patient with COVID-19 infection that was on therapeutic anticoagulation with apixaban for deep venous thrombosis (DVT). […] Three weeks later pending hospital discharge, the anticoagulation was switched to oral apixaban 10 mg twice daily. |
32834113 | They are telaprevir, temsirolimus, pimecrolimus, aminoglutethimide, apixaban, buspirone, lenalidomide, and pomalidomide. […] It is recommended that telaprevir, and pyridone-containing pharmaceuticals including aminoglutethimide, apixaban, buspirone, lenalidomide, and pomalidomide be repurposed for COVID-19 treatment after suitable validation and clinical trials. |
32868974 | Full dose tinzaparin was given for 2 days in hospital, followed by apixaban for 6 months. |
33119257 | An RMSD cutoff winnowed down the pool to 12, and free energy analysis (MM/PBSA) produced the final selection of 9 drugs: dihydroergotamine, midostaurin, ziprasidone, etoposide, apixaban, fluorescein, tadalafil, rolapitant, and palbociclib. |
33186991 | We conclude that COVID-19+ patients with moderate or severe illness benefit from anticoagulation and that apixaban has similar efficacy to enoxaparin in decreasing mortality in this disease. |
33240504 | Herein, we are presenting a case of co-occurrence of left ventricular thrombosis with pulmonary embolism in the setting of coronavirus 2019 with successful treatment with apixaban. |
33244512 | Apixaban appeared safe and efficacious in ICU patients with severe COVID-19 disease. |
33257399 | He was treated initially with an intravenous heparin infusion, which was changed to apixaban with a planned outpatient review in 3 months’ time. |
33282586 | After seven days, she was successfully extubated and was transferred to the medical service where her clinical course remained stable and subsequently discharged home on apixaban. |
33371000 | Having been commenced on apixaban 5 mg two times per day, he is currently asymptomatic. |
33520558 | He was initially started on low molecular weight heparin (LMWH) and was discharged on apixaban. |
33529622 | Patients with BHVs and AF treated with warfarin, dabigatran, rivaroxaban or apixaban between September 12, 2011 and June 18, 2020 were identified. |